BYSI
Price
$0.43
Change
-$0.07 (-14.00%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
20.39M
20 days until earnings call
Intraday BUY SELL Signals
TAOX
Price
$3.39
Change
-$0.16 (-4.51%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
26.53M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BYSI vs TAOX

BYSI vs TAOX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BYSI vs. TAOX commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BYSI is a StrongBuy and TAOX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BYSI with price predictions
Oct 21, 2026

BYSI's Stochastic Oscillator is sitting in oversold zone for 10 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BYSI's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +54.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BYSI advanced for three days, in 178 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 66 of 104 cases where BYSI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BYSI as a result. In 81 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for BYSI turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 48 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

BYSI moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BYSI crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BYSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

BYSI broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.573) is normal, around the industry mean (2.988). P/E Ratio (-2.917) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (31.056) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. BYSI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TAOX with price predictions
Oct 21, 2026

Momentum Indicator for TAOX turns negative, indicating new downward trend

TAOX saw its Momentum Indicator move below the 0 level on October 07, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned negative. In 88 of the 95 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TAOX turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 46 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

TAOX moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TAOX crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TAOX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for TAOX entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TAOX's RSI Oscillator exited the oversold zone, 27 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +9.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where TAOX advanced for three days, in 189 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

TAOX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. TAOX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.081) is normal, around the industry mean (3.638). P/E Ratio (2.148) is within average values for comparable stocks, (8.944). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.191) among similar stocks. P/S Ratio (30.303) is also within normal values, averaging (16.763).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TAOX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

FUNDAMENTALS RATINGS
BYSI vs TAOX: Fundamental Ratings
BYSI
TAOX
OUTLOOK RATING
1..100
9358
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9282
P/E GROWTH RATING
1..100
841
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BYSI's Valuation (23) in the Pharmaceuticals Major industry is significantly better than the same rating for TAOX (95) in the null industry. This means that BYSI’s stock grew significantly faster than TAOX’s over the last 12 months.

BYSI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as TAOX (100) in the null industry. This means that BYSI’s stock grew similarly to TAOX’s over the last 12 months.

BYSI's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as TAOX (99) in the null industry. This means that BYSI’s stock grew similarly to TAOX’s over the last 12 months.

TAOX's Price Growth Rating (82) in the null industry is in the same range as BYSI (92) in the Pharmaceuticals Major industry. This means that TAOX’s stock grew similarly to BYSI’s over the last 12 months.

BYSI's P/E Growth Rating (8) in the Pharmaceuticals Major industry is somewhat better than the same rating for TAOX (41) in the null industry. This means that BYSI’s stock grew somewhat faster than TAOX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BYSITAOX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BYSI: $0.50 vs. TAOX: $3.55)
Brand notoriety: BYSI and TAOX are both not notable
BYSI represents the Biotechnology, while TAOX is part of the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: BYSI: 17% vs. TAOX: 54%
Market capitalization -- BYSI: $18.3M vs. TAOX: $25.07M
BYSI [@Biotechnology] is valued at $18.3M. TAOX’s [@Investment Banks/Brokers] market capitalization is $25.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $590 to $293.71B. The average market capitalization across the [@Biotechnology] industry is $2.18B. The average market capitalization across the [@Investment Banks/Brokers] industry is $11.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BYSI’s FA Score shows that 2 FA rating(s) are green while TAOX’s FA Score has 0 green FA rating(s).

  • BYSI’s FA Score: 2 green, 3 red.
  • TAOX’s FA Score: 0 green, 5 red.
According to our system of comparison, BYSI is a better buy in the long-term than TAOX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BYSI’s TA Score shows that 4 TA indicator(s) are bullish while TAOX’s TA Score has 4 bullish TA indicator(s).

  • BYSI’s TA Score: 4 bullish, 6 bearish.
  • TAOX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BYSI and TAOX are a bad buy in the short-term.

Price Growth

BYSI (@Biotechnology) experienced а -15.52% price change this week, while TAOX (@Investment Banks/Brokers) price change was +1.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.09%. For the same industry, the average monthly price growth was -16.78%, and the average quarterly price growth was -13.10%.

Reported Earning Dates

BYSI is expected to report earnings on Nov 11, 2026.

TAOX is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Investment Banks/Brokers (-5.09% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

View a ticker or compare two or three
BYSI
Daily Signal:
Gain/Loss:
TAOX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

BYSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with GOSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
-5.13%
GOSS - BYSI
38%
Loosely correlated
+2.19%
CYTK - BYSI
37%
Loosely correlated
-1.70%
VNDA - BYSI
33%
Poorly correlated
-3.84%
TAOX - BYSI
31%
Poorly correlated
+4.88%
RCUS - BYSI
31%
Poorly correlated
-19.58%
More

TAOX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAOX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if TAOX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAOX
1D Price
Change %
TAOX100%
+4.88%
NCNA - TAOX
92%
Closely correlated
-2.94%
RNAC - TAOX
91%
Closely correlated
+0.39%
AGEN - TAOX
91%
Closely correlated
-0.31%
ALLR - TAOX
87%
Closely correlated
-0.62%
NRXP - TAOX
84%
Closely correlated
+0.38%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PL13.710.31
+2.31%
Planet Labs PBC
GRMN291.130.78
+0.27%
Garmin Ltd
INBK25.89-0.10
-0.38%
First Internet Bancorp
PRCT18.27-0.55
-2.92%
PROCEPT BioRobotics Corp
ACH0.22-0.04
-14.33%
Accendra Health Inc